Insider buying last 90 days
$162Kin 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 17 | Chuck Kyrish SVP & CFO | Purchase | $64K |
| Aug 12 | Mark Christopher Murray SVP - Acetyls | Purchase | $98K |
From Form 4 filings, dated to when each was filed.
Celanese moved this week on global price increases across its acetyl chain, covering acetic acid, vinyl acetate monomer, ethyl acetate and acetic anhydride, announced as effective immediately or as contracts allow. The move followed the company's Q2 2026 results, where EPS of $2.45 beat the estimate of $2.21, and management framed the increases as aimed at margin recovery in the Acetyl Chain business. Celanese also announced a separate price increase in its Engineered Materials segment, and the stock drew comparison pieces against peer Northern Technologies International during the same period.
CE closes at $45.92, down 2.5% on the day, sitting between its 50-day average of $45.40 and its 200-day average of $51.23, with the one-month return at 2.3% and the six-month return at -27.6%. The GekkoIndex reads 56.6, placing the stock in the Neutral zone after a five-day change of -4.3. Against a Gekko Fair Value of $85.83, the current price sits 46.5% below that level.
The next earnings date falls on 5 November, 37 days out and beyond a typical 20-trading-day holding window, with the prior report showing five beats in the last eight quarters and an average absolute reaction of 12.1%. Over the last 90 days, two open-market insider purchases totaling $161,746 have been recorded, alongside one trailblazer holder. Seasonality over five years shows an average 20-day return of 0.8% from this point, with gains in three of those years. Analyst coverage spans 13 firms, with 8 at buy and 5 at hold, and a consensus target of $63.24.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Celanese scores 4 supportive, 2 mixed and 0 headwinds across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive2 mixed0 headwinds
Averages disagree
Close $45.92 sits between the 50-day ($45.40) and 200-day ($51.23) averages, or the averages disagree.
See the chart56.6, Neutral
Reading 56.6 is in the Neutral zone.
See the GekkoIndex46.5% below
Price is 46.5% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 2 open-market insider purchases.
See smart moneyReports in 37 days
Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.
See earnings+0.8% on average
From this point in the calendar, the next 20 trading days averaged +0.8% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Celanese closed at $45.92 on Sep 28, 2026, +15.0% over the past year, inside a 52-week range of $35.13 to $70.70.
Use the left and right arrow keys to read daily values.
Put CE on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Celanese develops and supplies a broad range of specialty polymers to manufacturers around the globe. Its materials span elastomers, copolymers, liquid crystal polymers, reinforced plastics, and nylon or polypropylene formulations, which end up inside appliances, vehicles, buildings, clothing, gadgets, energy storage systems, filtration gear, medical tools and communications hardware. Many of these offerings carry long-established brand names that customers in these industries would recognize.
Internally, the business runs through two segments: Engineered Materials and Acetyl Chain. The Acetyl Chain unit turns out acetic acid, anhydride, acetate tow and flake, vinyl acetate monomers, emulsion polymers and formaldehyde-based chemicals, which get used in adhesives, paints, coatings, packaging, textiles, pharmaceuticals and building products like insulation and renders. Celanese moves its goods to market through a mix of direct sales, distributor networks, and relationships with equipment makers and suppliers.
The company dates back to 1912 and keeps its headquarters in Irving, Texas. Investors can find its stock listed on the NYSE under the ticker CE.
Celanese’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.6, in the Neutral zone, down 4.3 points over five sessions.
Down 4.3 points over five sessions, from the Accumulation zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 61 | +0.4% | +1.5% | ||
| Accumulation | 279 | −1.2% | −3.0% | ||
| Neutral (current zone) | 317 | −0.2% | −2.8% | ||
| Distribution | 14 | −0.9% | +3.2% | ||
| Selling | 1 | Too few readings yet | |||
Average CE share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Celanese trades 46.5% below Gekko Fair Value of $85.83, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Celanese shares are worth, recalculated every trading day.
$85.83
Gekko Fair Value, Sep 24, 2026
46.5% Undervalued
Insiders filed 2 open-market purchases in Celanese worth $162K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$162Kin 2 open-market purchases
| Filed | Insider | Type | Value |
|---|---|---|---|
| Aug 17 | Chuck Kyrish SVP & CFO | Purchase | $64K |
| Aug 12 | Mark Christopher Murray SVP - Acetyls | Purchase | $98K |
From Form 4 filings, dated to when each was filed.
No trades in CE were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Celanese has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds CE.
Celanese reports on Nov 5, 2026 (37 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 5, 2026
37 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 4, 2026 | $2.45 est $2.21 | $2.75B est $2.75B | −1.7% |
| May 5, 2026 | $0.85 est $0.90 | $2.34B est $2.34B | −9.6% |
| Feb 17, 2026 | $0.67 est $0.91 | $2.20B est $2.25B | −6.8% |
| Nov 6, 2025 | $1.34 est $1.27 | $2.42B est $2.25B | +11.8% |
| Aug 11, 2025 | $1.44 est $1.38 | $2.53B est $2.55B | −14.2% |
| May 5, 2025 | $0.57 est $0.37 | $2.39B est $2.46B | +6.7% |
| Feb 18, 2025 | $1.45 est $1.25 | $2.37B est $2.36B | −19.3% |
| Nov 4, 2024 | $2.44 est $2.85 | $2.65B est $2.70B | −27.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Celanese is $63.24, +37.7% from the last close, from 13 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 13 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 28 | Morgan Stanley | $58 | +26.3% |
| Sep 23 | Wells Fargo | $65 | +41.6% |
| Sep 11 | KeyBanc | $57 | +24.1% |
| Sep 10 | KeyBanc | $57 | +24.1% |
| Aug 26 | Alembic Global | $65 | +41.6% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 29, Celanese averaged +0.8% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.9% | 3 of 5 |
| Next 10 trading days | −0.2% | 2 of 5 |
| Next 15 trading days | +0.3% | 3 of 5 |
| Next 20 trading days | +0.8% | 3 of 5 |
| Next 30 trading days | −3.4% | 3 of 5 |
For scale, CE’s typical 20-trading-day move in either direction is about 7%.
Celanese’s market cap is $5.03B and revenue of $9.71B over the last twelve months.
Coverage of Celanese this week reads positive: 3 positive, 1 neutral and 1 negative headlines.
Celanese’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LINLinde | Accumulation | 2.8% below |
| ECLEcolab | Neutral | 8.2% above |
| APDAir Products and Chemicals | Accumulation | 11.9% below |
| DOWDow | Accumulation | 34.3% below |
| LYBLyondellBasell Industries | Accumulation | 12.3% below |
| ALBAlbemarle | Accumulation | 24.7% below |
A peer links to its own page where one exists.
Celanese’s market cap is $5.03B at the Sep 28, 2026 close of $45.92, with 109.7M shares outstanding.
The consensus analyst 12-month price target for Celanese is $63.24, +37.7% from the last close. Of the 13 firms that rated the stock in the last 90 days, 8 rate it a buy, 5 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Celanese is undervalued: the Sep 28, 2026 close of $45.92 is 46.5% below Gekko Fair Value of $85.83. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Celanese is expected to report on Nov 5, 2026 (37 days away). Analysts expect earnings of $1.55 per share on revenue of $2.62B. Celanese beat the earnings estimate in 5 of its last 8 reports, moving 12.1% on average across the report.
Celanese’s 52-week high is $70.70 and its 52-week low is $35.13; it closed at $45.92 on Sep 28, 2026, +15.0% over the past year. Over the last five years the shares peaked at $176.50 on Jan 5, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (fair value, smart money, earnings risk and seasonality), 2 as mixed (trend and gekkoindex). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.